Tevogen Bio Inc. (TVGN)
NASDAQ: TVGN
· Real-Time Price · USD
0.84
0.08 (10.76%)
At close: Sep 22, 2025, 3:59 PM
0.84
0.49%
After-hours: Sep 22, 2025, 07:58 PM EDT
10.76% (1D)
Bid | 0.79 |
Market Cap | 164.33M |
Revenue (ttm) | 396.59K |
Net Income (ttm) | -31.2M |
EPS (ttm) | -0.19 |
PE Ratio (ttm) | -4.4 |
Forward PE | -3.16 |
Analyst | Buy |
Dividends | n/a |
Ask | 0.86 |
Volume | 638,668 |
Avg. Volume (20D) | 855,003 |
Open | 0.76 |
Previous Close | 0.76 |
Day's Range | 0.76 - 0.84 |
52-Week Range | 0.26 - 3.09 |
Beta | -0.76 |
Ex-Dividend Date | n/a |
About TVGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TVGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TVGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+7.74%
Tevogen Bio Holdings shares are trading higher aft...
Unlock content with
Pro Subscription
4 months ago
-5.52%
Tevogen Bio Holdings shares are trading higher after the company reaffirmed its oncology pipeline revenue forecast, projecting $1 billion in its launch year and a cumulative five-year estimate of $10 billion to $14 billion.